share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Treco Douglas A

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Treco Douglas A

CRISPR Therapeutics | 4：持股变动声明-董事 Treco Douglas A
美股sec公告 ·  05/31 16:21
Moomoo AI 已提取核心信息
Douglas A. Treco, associated with CRISPR Therapeutics AG [CRSP], was involved in a transaction on May 30, 2024. The specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. As this information is crucial for investors, further updates are anticipated to provide a clearer picture of the transaction's impact on CRISPR Therapeutics' stock.
Douglas A. Treco, associated with CRISPR Therapeutics AG [CRSP], was involved in a transaction on May 30, 2024. The specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. As this information is crucial for investors, further updates are anticipated to provide a clearer picture of the transaction's impact on CRISPR Therapeutics' stock.
与CRISPR Therapeutics AG [CRSP] 相关的道格拉斯·特雷科于2024年5月30日参与了一笔交易。有关交易性质的具体细节，例如行动类型、状态、所涉股票数量、交易价格以及行动后由此产生的持股数量，尚未披露。由于这些信息对投资者至关重要，预计将进一步更新该交易对CRISPR Therapeutics股票的影响。
与CRISPR Therapeutics AG [CRSP] 相关的道格拉斯·特雷科于2024年5月30日参与了一笔交易。有关交易性质的具体细节，例如行动类型、状态、所涉股票数量、交易价格以及行动后由此产生的持股数量，尚未披露。由于这些信息对投资者至关重要，预计将进一步更新该交易对CRISPR Therapeutics股票的影响。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息